FTC report finds 'pay for delay' patent settlements on the rise

Patent dispute settlements between brand-name and generic drug makers have jumped sharply, the Federal Trade Commission has found, warning that such deals may be anti-competitive. There were 40 potential "pay for delay" deals in fiscal year 2012 involving drugs with combined sales of more than $8.3 billion, compared with 28 in FY 2011. It's the most of any year since the FTC began collecting data in 2003.

Source: http://www.law.com/jsp/law/sign_me_in.jsp?article=http://www.law.com/jsp/nlj/PubArticleNLJ.jsp?id=1202584891452&rss=newswire

legal advice legal advice online legal aid legal aid eugene oregon legal aid society